Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
03/23/2005 | EP1515978A1 Sulfur-containing phospholipid derivatives |
03/23/2005 | EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
03/23/2005 | EP1515956A1 Peptide deformylase inhibitors |
03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
03/23/2005 | EP1515940A2 Aminoalkoxy-functional chalcones |
03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
03/23/2005 | EP1515734A1 Honey-based skin care preparation |
03/23/2005 | EP1515731A1 Anti-spasmodic comprising xenon |
03/23/2005 | EP1515729A1 Quaternised ammonium cyclodextrin compounds |
03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
03/23/2005 | EP1515713A1 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents |
03/23/2005 | EP1515710A1 Method of treating rosacea by topical application of a cyclohexane derivative |
03/23/2005 | EP1515698A2 Liposomes containing biologically active compounds |
03/23/2005 | EP1515615A1 Nutritional composition for detoxification and cancer prevention |
03/23/2005 | EP1515607A2 Antimicrobial compositions, products and methods employing same |
03/23/2005 | EP1328540B1 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
03/23/2005 | EP1311285B1 Liquid pharmaceutical composition containing an erythropoietin derivative |
03/23/2005 | EP1280795B1 N-substituted carbamoyloxyalkyl-azolium derivatives |
03/23/2005 | EP1235566B1 Injectable valnemulin formulation |
03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
03/23/2005 | EP0973886B1 Method and conjugate for treating helicobacter pylori infections |
03/23/2005 | EP0968297B1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
03/23/2005 | EP0832241B1 Mutants of streptococcal toxin a and methods of use |
03/23/2005 | EP0662092B1 Activity-dependent neurotrophic factor |
03/23/2005 | CN1599744A Beta -2'-or 3'-halonucleosides |
03/23/2005 | CN1599741A Thioether substituted imidazoquinolines |
03/23/2005 | CN1599740A Amide substituted imidazopyridines |
03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |
03/23/2005 | CN1599738A Urea substituted imidazopyridines |
03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
03/23/2005 | CN1599726A Pyrimidine compounds |
03/23/2005 | CN1599702A Antimicrobial alkali-silicate glass ceramic and the use thereof |
03/23/2005 | CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
03/23/2005 | CN1599619A Methods and compositions for treating dermal lesions |
03/23/2005 | CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid |
03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
03/23/2005 | CN1599601A Plaster for the treatment of dysfunctions and disorders of nails |
03/23/2005 | CN1599599A Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
03/23/2005 | CN1597964A Expression and purification of M protein in recombined SARS coronary virus |
03/23/2005 | CN1597957A A group nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its segment and application |
03/23/2005 | CN1597956A Trans menbrance type and secretory type HIV Gag antigen code gene and AIDS vaccine containing said gene |
03/23/2005 | CN1597941A 10-23 desoxyribonuclease of bacillus resisting tubercle branch |
03/23/2005 | CN1597698A Cation antibacterial peptide |
03/23/2005 | CN1597695A Active GSLL-39 fragment of gene recombination human antibacterial peptide mh CAP-18 and its preparation method and use |
03/23/2005 | CN1597694A Meningococcal antigens |
03/23/2005 | CN1597691A Method of improving king crab element gene with higher antibacterial activity and high effect expression |
03/23/2005 | CN1597684A Sodium ceftriaxone and its preparation method |
03/23/2005 | CN1597660A Method of preparing aminopropylene kind antifungus medicine |
03/23/2005 | CN1597656A Eugenol ibuprofen ester medical compound and its preparation and preparation method |
03/23/2005 | CN1597008A Local preparation containing poloxamer and other microbe killing agent and applicator |
03/23/2005 | CN1596982A Composition of nanometer SOD and astragalus root or its extract and its preparation method |
03/23/2005 | CN1596980A AntiAids sexual contact protective agent and its production method |
03/23/2005 | CN1596978A Combined vaccine for hepatitis A, B virus and its preparation method |
03/23/2005 | CN1596973A Interferon-ginseng diol saponin slow-releasing tablet |
03/23/2005 | CN1596950A Mixture for treating acute condyloma |
03/23/2005 | CN1596949A Medicinal composition for treating hilar pulmonistuberculosis and its preparation method |
03/23/2005 | CN1596948A Antibicrobial and bacteria inhibiting external use medicine for gynecopathy |
03/23/2005 | CN1596937A Medicine for treating scrofula |
03/23/2005 | CN1596926A Composition for preventing SARS and homologous SARS syndrome |
03/23/2005 | CN1596925A Composition for treating and/or relaxing SARS and SARS kind syndrome |
03/23/2005 | CN1596919A Application for treating hepatism |
03/23/2005 | CN1596908A Sterilization bacteria inhibition compound iodophor medicine and its preparation and preparation technology |
03/23/2005 | CN1596898A Biammonium glycyrrhizate powder-injection and its preparation method |
03/23/2005 | CN1596897A Itraconazole injection and its preparation method |
03/23/2005 | CN1596894A Use of berberine as anti fungus medicine synergist |
03/23/2005 | CN1596892A Use of abedol in preparation of medicine for preventing and treating hepatitis B, HIV virus |
03/23/2005 | CN1596890A Medicine having antivirus action |
03/23/2005 | CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method |
03/23/2005 | CN1596886A Application of albi multisulfoxide and its salt in preparing medicine for preventing and treating respiratory tract virus infestation |
03/23/2005 | CN1596878A Oral medicine possessing colon orientation medicine releasing function |
03/23/2005 | CN1194093C Bacterial plasmids |
03/23/2005 | CN1194092C Medusa cystatin Protease inhibitor gene, and expression and use therof |
03/23/2005 | CN1194015C Effective renaturation liquid of recombinant human interon inclusion boby and renaturation method |
03/23/2005 | CN1194014C Coupled cmpound of hematopoietin and polyethylene glycol |
03/23/2005 | CN1194008C Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
03/23/2005 | CN1194005C Producing influenza killed vaccine by Sepharose 4FF column chromatography technology |
03/23/2005 | CN1194003C Small RNA molecule for inhibiting SARS virus infestion |
03/23/2005 | CN1193991C Method for preparing 2.5-diamino-4.6-dichloropyrimidine |
03/23/2005 | CN1193791C Ordered molecualr presentation of antigens. method of preparation and use |
03/23/2005 | CN1193787C Use of cordyceps sinensis |
03/23/2005 | CN1193780C Excernally applied plaster using paper as paper as carrier for treating beriberi |
03/23/2005 | CN1193777C Chinese medicine for treaing cold by omphalotherapy and its preparing process |
03/23/2005 | CN1193766C Gardenia total glydcoside composite for treating hepatitis and its preparation method |
03/23/2005 | CN1193765C Use of 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-one-4H-1 benzopyrany 1-7-hydroxy-beta-D-glucuronic acid in producing medicine |
03/23/2005 | CN1193747C Diphenyl ketoaldehyde derivatives with anti-HIV activity |
03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
03/23/2005 | CN1193743C Multilayer pharmaceutical product for release in the colon |
03/23/2005 | CN1193736C Medicine for eliminating bromhidrosis |
03/23/2005 | CN1193730C Use of glyceryl triacetate for treating onychomycoses |
03/22/2005 | US6870043 For broad use in therapy and prevention including antisense agents and vaccines |
03/22/2005 | US6870042 Mutants of streptococcal toxin A and methods of use |
03/22/2005 | US6870032 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form |
03/22/2005 | US6869975 Linked biaryl compounds |
03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
03/22/2005 | US6869971 UCS1025 derivatives |
03/22/2005 | US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |